Vis enkel innførsel

dc.contributor.authorTøndervik, Anne
dc.contributor.authorAarstad, Olav Andreas
dc.contributor.authorAune, Randi
dc.contributor.authorMaleki, Susan
dc.contributor.authorRye, Philip D
dc.contributor.authorDessen, Arne
dc.contributor.authorSkjåk-Bræk, Gudmund
dc.contributor.authorSletta, Håvard
dc.date.accessioned2022-10-12T12:21:45Z
dc.date.available2022-10-12T12:21:45Z
dc.date.created2021-01-19T11:46:35Z
dc.date.issued2020
dc.identifier.citationMarine Drugs. 2020, 18:565 (11), 1-14.en_US
dc.identifier.issn1660-3397
dc.identifier.urihttps://hdl.handle.net/11250/3025609
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectpotentiation of antibiotic effecten_US
dc.subjectguluronate oligomersen_US
dc.subjectmannuronan C-5 epimerasesen_US
dc.subjectseaweed and bacterial alginateen_US
dc.titleExploiting mannuronan C-5 epimerases in commercial alginate productionen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).en_US
dc.source.pagenumber1-14en_US
dc.source.volume18en_US
dc.source.journalMarine Drugsen_US
dc.source.issue11en_US
dc.identifier.doi10.3390/md18110565
dc.identifier.cristin1874181
dc.source.articlenumber565en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal